✦ LIBER ✦

Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy

✍ Scribed by Giuseppe Giaccone; Renee B. Iacona; Abderrahim Fandi; Mette Janas; Judith S. Ochs; Roy S. Herbst; David H. Johnson

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 494 KB
Volume: 135
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-008-0466-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prognostic-factor risk index in advanc

A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy

✍ Tetsu Shinkai; Kenji Eguchi; Yasutsuna Sasaki; Tomohide Tamura; Yuichiro Ohe; Ak 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 654 KB

Docetaxel and granulocyte colony-stimula

Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial

✍ K. Alexopoulos; C. Kouroussis; N. Androulakis; E. Papadakis; M. Vaslamatzis; S. 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 90 KB

Cetuximab-based Therapy is Effective in

Cetuximab-based Therapy is Effective in Chemotherapy-naïve Patients with Advanced and Metastatic Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials

✍ Ezzeldin M. Ibrahim; Khaled M. Abouelkhair; Osama A. Al-Masri; Najeeb C. Chaudry 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 295 KB

A phase I study of larotaxel (XRP9881) a

A phase I study of larotaxel (XRP9881) administered in combination with carboplatin in chemotherapy-naïve patients with stage IIIB or stage IV non-small cell lung cancer

✍ Francisco Robert; Karen Harper; Judie Ackerman; Sunil Gupta 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 284 KB

Detection of epidermal growth factor rec

Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer

✍ Chen He; Ming Liu; Chengzhi Zhou; Jiexia Zhang; Ming Ouyang; Nanshan Zhong; Jun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 260 KB 👁 2 views

## Abstract The high frequency of epidermal growth factor receptor (__EGFR__) mutations in tyrosine kinase inhibitor‐responsive non‐small‐cell lung cancer (NSCLC) cases is now well established, highlighting the predictive value of activating __EGFR__ mutations in guiding the clinical use of __EGFR_

Accuracy of epidermal growth factor rece

Accuracy of epidermal growth factor receptor gene mutation analysis by direct sequencing method based on small biopsy specimens from patients with non-small cell lung cancer: analysis of results in 19 patients

✍ Katsuhiro Masago; Shiro Fujita; Tadashi Mio; Masataka Ichikawa; Keiichiro Sakuma 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 222 KB